47 Results for "

Anabolic

" in MedChemExpress (MCE) Product Catalog:
Products (47)

47 Results for "Anabolic" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-N1993
CAS No.: 82517-12-2
5-Methyl-7-methoxyisoflavone is an orally active anti-oxidant with remyelinating activity. 5-Methyl-7-methoxyisoflavone inhibits the enzyme aromatase, interfering with the normal metabolic pathways of testosterone. 5-Methyl-7-methoxyisoflavone is a non-steroidal anabolic isoflavone, used as a anabolic agent. 5-Methyl-7-methoxyisoflavone shows better potency increasing muscle mass and endurance than Ipriflavone (HY-N0094). 5-Methyl-7-methoxyisoflavone can be used for fat loss besides the maintenance of low cholesterol level and strengthen bones. 5-Methyl-7-methoxyisoflavone is the inhibitor for NF-κB .
3
3 Cited Publications
Cat. No.: HY-P1252
CAS No.: 12583-68-5
Research Areas:  

Metabolic Disease

Parathyroid Hormone (1-34), bovine is a potent parathyroid hormone (PTH) receptor agonist. Parathyroid Hormone (1-34), bovine increases calcium and inorganic phosphate levels in vivo. Parathyroid Hormone (1-34), bovine can be used for th reseach of osteoporosis .
1
1 Cited Publications
Cat. No.: HY-P99590A
Synonyms: RAP-011
Sotatercept (mIgG2a) (RAP-011), the murine homolog of Sotatercept (ACE-011) (HY-P99590), is a soluble activin receptor type IIA (ActRIIA) ligand trap. Sotatercept (mIgG2a) inhibits the binding of activin A and other members of the TGF-β superfamily (such as Activin A/B, GDF11 and BMP9/10) to their receptors by combining and neutralizing them, thereby regulating cell proliferation and differentiation. Sotatercept (mIgG2a) mainly inhibits the SMAD2/3 signaling pathway, and can be used in various diseases such as chronic kidney disease. Sotatercept (mIgG2a) reduces the expression of erythropoietic hepcidin (ERFE), regulates iron metabolism, and promotes red blood cell production. Sotatercept (mIgG2a) has a dual effect of promoting bone formation (anabolic) and inhibiting bone resorption (catabolic) .
1
1 Cited Publications
Cat. No.: HY-122025
CAS No.: 870888-46-3
Purity:  99.94%
Target:  

Androgen Receptor

Research Areas:  

Metabolic Disease

AC-262536 is a selective and non-steroidal androgen receptor modulators (SARMs) with beneficial anabolic effects. AC-262536 exhibits potent agonist activity at the androgen receptor, with an affinity in the low nanomolar range (1-10 nM) .
Cat. No.: HY-114974
CAS No.: 256382-08-8
Purity:  ≥99.0%
Synonyms: ONO-4819; ONO-AE1-734
Research Areas:  

Others Inflammation/Immunology

Rivenprost (ONO-4819; ONO-AE1-734) is a selective agonist for prostaglandin E receptor EP4 with Ki of 0.7 nM. Rivenprost exhibits hepatoprotective and bone anabolic effects .
Cat. No.: HY-P2832
CAS No.: 9013-18-7
Synonyms: ACS
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease Cancer

Acyl coenzyme A synthetase (ACS), namely acetyl coenzyme A synthetase, is often used in biochemical research. Acyl coenzyme A synthetase can catalyze the activation of fatty acids by coenzyme A through a two-step thioesterification reaction to produce acyl coenzyme A, and then participate in a variety of anabolic and catabolic lipid metabolism pathways, and participate in the TCA cycle in aerobic respiration .
Cat. No.: HY-N2489
CAS No.: 56786-63-1
Synonyms: Brassinosteroid BB 16; DI 31
Research Areas:  

Others

5α-Hydroxy-laxogenin (Brassinosteroid BB 16; DI 31) is a derivative of laxogenin, a spirostane-type steroid. 5α-Hydroxy-laxogenin serves as a plant-derived anabolic agent and is used as a dietary supplement .
Cat. No.: HY-P99857
CAS No.: 1629605-31-7
Synonyms: PF-06252616

Target:  

TGF-beta/Smad

Research Areas:  

Metabolic Disease

Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular dystrophy (DMD) .
Cat. No.: HY-101734
CAS No.: 3764-87-2
Purity:  99.09%
Synonyms: 7α-Methylnandrolone
Target:  

Androgen Receptor

Research Areas:  

Metabolic Disease

Trestolone is a synthetic anabolic-androgenic steroid (AAS) of the nandrolone (19-nortestosterone) group.
Cat. No.: HY-P1777
CAS No.: 135861-49-3
Synonyms: Insulin-like Growth Factor I (24-41)
Target:  

IGF-1R

IGF-I (24-41) (Insulin-like Growth Factor I (24-41)) is amino acids 24 to 41 fragment of IGF-I. IGF-I, a 70 aa polypeptide hormone, is a trophic factor for both neurons and glial cells. IGF-I is partly responsible for systemic growth hormone (GH) activities. IGF-I has anabolic, antioxidant, anti-inflammatory and cytoprotective actions. IGF-I (24-41) regulates somatic growth and behavioral development .
Cat. No.: HY-145121
CAS No.: 2871872-79-4
Purity:  99.93%
Target:  

CDK

Research Areas:  

Metabolic Disease

DS96432529 is a potent and orally active bone anabolic agent through CDK8 inhibition.
Cat. No.: HY-30215
CAS No.: 13748-90-8
(S)-Leucic acid is a metabolite of Leucine. (S)-Leucic acid has anabolic effects, particularly promoting muscle protein synthesis. (S)-Leucic acid can be used in the diagnosis of pregnancy loss .
Cat. No.: HY-124156A
CAS No.: 2989396-34-9
Purity:  99.24%
Target:  

Wnt

Research Areas:  

Metabolic Disease

KY-02327 acetate, a metabolically stabilized KY-02061 analog, is a potent Dishevelled (Dvl)-CXXC5 interaction inhibitor. KY-02327 acetate shows an activating effect on the Wnt/β-catenin pathway, resulting in promotion of osteoblast differentiation .
Cat. No.: HY-P3075
CAS No.: 112540-82-6
Synonyms: pTHrP (1-34)
Research Areas:  

Inflammation/Immunology

pTH-Related Protein (1-34) (human, mouse, rat), a fragment of parathyroid hormone-related protein, is an anabolic agent. pTH-Related Protein (1-34) (human, mouse, rat) can be used for postmenopausal osteoporosis study .
Cat. No.: HY-137236
CAS No.: 33526-41-9
Target:  

Drug Metabolite

Research Areas:  

Metabolic Disease

6β-Hydroxy metandienone is an anabolic androgenic steroid metabolite of Metandienone .
Cat. No.: HY-171048
CAS No.: 928122-40-1
Target:  

Androgen Receptor

Research Areas:  

Endocrinology Cancer

GTx-027 is an orally active and non-steroidal selective androgen receptor modulator (SARM). GTx-027 shows androgen receptor (AR) transactivation effects with the EC50 of 1.8 nM. GTx-027 acts selectively increase muscle weight (anabolic) without affecting secondary sexual organs (androgenic). GTx-027 has the protential for the study of breast cancer and stress urinary incontinence (SUI) .
Cat. No.: HY-113233
CAS No.: 33036-33-8
Target:  

Androgen Receptor

Research Areas:  

Metabolic Disease

19-Noretiocholanolone is an anabolic androgenic steroid metabolite of Nandrolone .
Cat. No.: HY-176098
CAS No.: 3070439-39-0
Target:  

Drug Derivative

Research Areas:  

Others

Δ6-Testosterone enanthate is a synthetic anabolic steroid (AAS), being the Δ6-isomer of testosterone enanthate.
Cat. No.: HY-P4838
CAS No.: 154765-04-5
Target:  

Peptides

Research Areas:  

Others

pTH (2-38) (human) is involved in the anabolic action of bone. PTH (2-38) can increase the level of serum INS-PTH (complete N-terminal specific PTH) .
Cat. No.: HY-124156
CAS No.: 2093407-25-9
Target:  

Wnt

Research Areas:  

Metabolic Disease

KY-02327, a metabolically stabilized KY-02061 analog, is a potent Dishevelled (Dvl)-CXXC5 interaction inhibitor. KY-02327 shows an activating effect on the Wnt/β-catenin pathway, resulting in promotion of osteoblast differentiation .